ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "osteoarthritis and pain"

  • Abstract Number: 1556 • 2012 ACR/ARHP Annual Meeting

    The Effect of Ginger Therapy On Symptoms of Osteoarthritis: An Open Pilot Study

    Tessa Therkleson, Nursing, Edith Cowan University, Perth, Australia

    Background/Purpose: Osteoarthritis (OA) is a painful, progressive disease of synovial joints characterised by deterioration of cartilage and bone and inflammation. Osteoarthritis of the knee and…
  • Abstract Number: 2631 • 2012 ACR/ARHP Annual Meeting

    Radiographic Osteoarthritis Severity Is Associated with an Increased Risk of Developing Knee Pain: Findings From the Osteoarthritis Initiative

    Jingbo Niu1, David T. Felson2, Tuhina Neogi3 and Yuqing Zhang4, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Clinical Epidemiology, Boston Univ School of Medicine, Boston, MA, 4School of Medicine, Boston Univ School of Medicine, Boston, MA

    Background/Purpose : While knee pain is a major complaint from subjects with knee osteoarthritis (OA), most epidemiologic studies have found only weak to moderate associations…
  • Abstract Number: 1126 • 2012 ACR/ARHP Annual Meeting

    Comparison between Osteoartritis Initiative and CHECK study (Cohort Hip & Cohort Knee); Development of pain and function during 4 years follow-up

    Janet Wesseling1, Sita M.A. Bierma-Zeinstra2, Margreet Kloppenburg3, Johannes WJ Bijlsma4 and CHECK steering group5, 1Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Orthopaedics and General Practice, Erasmus MC - University Medical Center, Rotterdam, Netherlands, 3Department Rheumatology and Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands, Leiden, Netherlands, 4Dept of Rheumatology & Immun, University Medical Center Utrecht, Utrecht, Netherlands, 5Dept of Rheumatology & Immun, University Medical Center Utrecht, Utrecht

    Background/Purpose:  Pain and disability related to osteoarthritis (OA) may generally be considered to be chronic, but it is known that its course can be very…
  • Abstract Number: 1128 • 2012 ACR/ARHP Annual Meeting

    Different of Patterns Knee Pain Trajectories: Longitudinal Data From the Osteoarthritis Initiative (OAI)

    Joseph Devich Jr.1, Michael J. Hannon2, Zhijie Wang2, Robert M. Boudreau3 and C. Kent Kwoh4, 1Imrp, UPMC Shadyside​, Pittsburgh, PA, 2Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 3Epidemiology, University of Pittsburgh, Pittsburgh, PA, 4School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Knee osteoarthritis (KOA) is one of the most common forms of arthritis and the most common cause of disability among the elderly.  Knee pain…
  • Abstract Number: 1135 • 2012 ACR/ARHP Annual Meeting

    Combined Glucosamine and Chondroitin Sulfate, Once of Three Times Daily, Provide Clinically Relevant Analgesia in Knee Osteoarthritis

    Jose R. Provenza1, Samuel K. Shinjo2, Joyce M. Silva3, Carla RGS. Peron4 and Francisco AC Rocha5, 1Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, 2Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 3Clinical Research, Sao Paulo, Brazil, 4Clinical Research, Laboratórios Aché Ltda, Sao Paulo, Brazil, 5Rheumatology, Brazilian Registry of Spondyloarthritis, São Paulo, Brazil

    Background/Purpose: The analgesic efficacy of combined glucosamine and chondroitin sulfate (CS) in knee osteoarthritis (OA) remains controversial. Criticism to previous studies includes small sample size,…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology